Therapeutic agent with quantitative consumption marker and method of monitoring therapeutic agent consumption
Abstract
(57) Each thing which is examined by the quantitive compliance marker and the related method for monitoring the patient according to the prescription of drug combined with the summary compliance marker, which is and whose necessity quantitive-related specific carries out new, and is lost to a medicine was discovered. The method for monitoring whether such a compliance marker and a patient follow directions, Use with the given dose which can measure the benzodiazepines or the non-metabolic substance of an inactive substance, i. E. , weak acid, in combination with a basic medicine pharmacologically, compliance marker concentration is made to correlate with basic medicine concentration, and the quantity of the actual medicine taken in is determined.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
44 members in 8 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 71501696 | United States of America | A | |
| 9716416 | United States of America | W |
Members44
| Document | Office | Kind | |
|---|---|---|---|
| CA2175584A1 | Canada | A1 | |
| WO9512812A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU8087394A | Australia | A | |
| US5547878A | United States of America | A | |
| EP0748444A1 | European Patent Office (EPO) | A1 | |
| US5652146A | United States of America | A | |
| EP0748444A4 | European Patent Office (EPO) | A4 | |
| JPH09508967A | Japan | A | |
| CA2265795A1 | Canada | A1 | |
| CA2526433A1 | Canada | A1 | |
| WO9812557A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU4482697A | Australia | A | |
| US5776783A | United States of America | A | |
| AU698403B2 | Australia | B2 | |
| CA2295905A1 | Canada | A1 | |
| WO9902983A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU8280898A | Australia | A | |
| US5908788A | United States of America | A | |
| US5955370A | United States of America | A | |
| EP0944828A1 | European Patent Office (EPO) | A1 | |
| EP0944828A4 | European Patent Office (EPO) | A4 | |
| EP0995114A1 | European Patent Office (EPO) | A1 | |
| US6124136A | United States of America | A | |
| JP2001507118A | Japan | A | |
| JP2001509601A | Japan | A | |
| AU736645B2 | Australia | B2 | |
| AU4806301A | Australia | A | |
| AU742863B2 | Australia | B2 | |
| AU758193B2 | Australia | B2 | |
| EP0748444B1 | European Patent Office (EPO) | B1 | |
| AT245814T | Austria | T | |
| ATE245814T1 | Austria | T1 | |
| DE69432976D1 | Germany | D1 | |
| EP0944828B1 | European Patent Office (EPO) | B1 | |
| AT263371TThis record | Austria | T | |
| ATE263371T1 | Austria | T1 | |
| DE69728418D1 | Germany | D1 | |
| EP0995114A4 | European Patent Office (EPO) | A4 | |
| CA2175584C | Canada | C | |
| CA2295905C | Canada | C | |
| CA2265795C | Canada | C | |
| JP4179748B2 | Japan | B2 | |
| JP4389005B2 | Japan | B2 | |
| CA2526433C | Canada | C |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 97943330
Titles2
- German
- THERAPEUTISCHES AGENZ MIT QUANTITATIVEM VERBRAUCHSMARKER UND METHODE ZUM NACHWEIS DES AGENZVERBRAUCHS
- English
- THERAPEUTIC AGENCY WITH QUANTITATIVE CONSUMER MARKER AND METHOD FOR IDENTIFYING AGENT CONSUMPTION
Classification
- CPC, 6
- G01N33/493
- G01N33/94
- G01N33/948
- Y10S436/808
- Y10S436/901
- Y10T436/173845
- IPC, 6
- A61K31 515
- A61K31 5513
- A61K45 00
- G01N33 15
- G01N33 493
- G01N33 94